Dejter-Juszynski M, Harpaz N, Flowers H M, Sharon N
Eur J Biochem. 1978 Feb;83(2):363-73. doi: 10.1111/j.1432-1033.1978.tb12102.x.
Highly glycosylated, water-soluble ABH-specific sphingolipids, designated macroglycolipids, were isolated in high yield, up to 5 mg per unit of blood, from the crude human-erythrocyte-membrane glycoprotein fraction which is obtained by extraction of the membranes with chloroform/methanol/water. Both serological tests and radioactive labelling experiments indicated that these substances, rather than the glycoproteins, are the principal ABH-components in this fraction. The activities of A-specific, B-specific and H-specific macroglycolipids were very high, approximately 0.1 microgram inhibiting four hemagglutinating doses of the respective agglutinating reagents, and were thus comparable to those of secreted blood-group ABH-specific glycoproteins. The substances were stable to mild alkaline conditions. They contained fucose, galactose, glucosamine, glucose, sialic acid, sphingosine and fatty acids; blood-group-A-specific substances contained, in addition, galactosamine. No amino acids were detected. Assuming one glycosyl residue per molecule, the average number of sugars in A and B macroglycolipids was 31, and their molecular weights approximately 6100. The presence of beta-D-galactosidase-labile and sialic acid residues indicated that these substances contain nonreducing termini additional to the ABH immunodeterminants. In the B macroglycolipid, the ratio between nonreducing terminal alpha-D-galactopyranosyl and beta-D-galactopyranosyl residues was 1.7:1.0. The macroglycolipids formed clear aqueous solutions at concentrations as high as 30 mg/ml, were insoluble in 60--70% aqueous ethanol, and did not migrate on thin-layer chromatography unless they were acetylated. Polyacrylamide gel electrophoresis in the presence of sodium dodecylsulfate showed the macroglycolipids to be a heterogeneous mixture migrating throughout most of the region in which the periodic acid/Schiff-positive membrane glycoproteins are found. On the basis of the evidence presented, it is concluded that macroglycolipids are the predominant ABH-specific component in human erythrocyte membranes, and that they most likely account for previous observations of ABH activity in membrane glycoprotein fractions.
从用人红细胞膜用氯仿/甲醇/水提取得到的粗制人红细胞膜糖蛋白组分中,以高产率分离出了高度糖基化的水溶性ABH特异性鞘脂,即巨糖脂,每单位血液可达5毫克。血清学试验和放射性标记实验均表明,这些物质而非糖蛋白是该组分中的主要ABH成分。A特异性、B特异性和H特异性巨糖脂的活性非常高,约0.1微克可抑制相应凝集试剂的四个血凝剂量,因此与分泌型血型ABH特异性糖蛋白的活性相当。这些物质对温和碱性条件稳定。它们含有岩藻糖、半乳糖、葡糖胺、葡萄糖、唾液酸、鞘氨醇和脂肪酸;血型A特异性物质还含有半乳糖胺。未检测到氨基酸。假设每个分子有一个糖基残基,A和B巨糖脂中糖的平均数量为31,其分子量约为6100。β-D-半乳糖苷酶不稳定和唾液酸残基的存在表明,这些物质除了ABH免疫决定簇外还含有非还原末端。在B巨糖脂中,非还原末端α-D-吡喃半乳糖基与β-D-吡喃半乳糖基残基的比例为1.7:1.0。巨糖脂在浓度高达30毫克/毫升时形成清澈的水溶液,不溶于60 - 70%的乙醇水溶液,除非乙酰化否则在薄层色谱上不迁移。在十二烷基硫酸钠存在下的聚丙烯酰胺凝胶电泳显示,巨糖脂是一种异质混合物,在发现高碘酸/席夫阳性膜糖蛋白的大部分区域迁移。根据所提供的证据,得出结论:巨糖脂是人类红细胞膜中主要的ABH特异性成分,它们很可能解释了先前在膜糖蛋白组分中观察到的ABH活性。